Table 1.

Pharmacokinetics characterization of rD′D3-FP

SpeciesTreatmentCL, mL/h/kgMRT, ht1/2, h
FVIII-ko mouse rD′D3-FP (0.286-28.6 mg/kg, 100 IU/kg FVIII) 1.2 ± 0.4 61.0 ± 15.0 47.0 ± 13.0 
VWF (Haemate, 106 IU/kg FVIII, 290 IU/kg VWF) 23.6 1.8 5.1 
Fold difference 20* 34 9 
VWF-ko mouse rD′D3-FP (2.86 mg/kg, 100 IU/kg FVIII) 1.3 49.0 34.0 
NMRI mouse rD′D3-FP (2.86-28.6 mg/kg, 100 IU/kg FVIII) 2.4 ± 0.1 33.0 ± 4.0 26.0 ± 2.0 
Rat rD′D3-FP (0.14-28.6 mg/kg, 200 IU/kg FVIII); rD′D3-FP (2.86-28.6 mg/kg, 100, 300, 1000 IU/kg FVIII) 1.2 ± 0.1; 1.2 ± 0.1 55.1 ± 5.7; 59.5 ± 5.9 39.2 ± 3.9; 42.7 ± 4.2 
VWF (pdVWF, 400 IU/kg) 68.2 1.1 1.3 
Fold difference 59*; 57* 50; 54* 30; 33* 
Rabbit rD′D3-FP (1.4-8.6 mg/kg, 150 IU/kg FVIII) 0.5 ± 0.1 162.0 ± 17.0 112.0 ± 12.0 
VWF (pdVWF, 300 IU/kg) 22.2 4.0 4.2 
Fold difference 44* 41 27 
Cynomolgus monkey rD′D3-FP (7.15-28.6 mg/kg) 0.6-0.7 115.0-151.0 92.0-116.0 
VWF (pdVWF, 500 IU/kg) 5.21 15.5 11.3 
Fold difference 8-9* 7-10 8-10 
SpeciesTreatmentCL, mL/h/kgMRT, ht1/2, h
FVIII-ko mouse rD′D3-FP (0.286-28.6 mg/kg, 100 IU/kg FVIII) 1.2 ± 0.4 61.0 ± 15.0 47.0 ± 13.0 
VWF (Haemate, 106 IU/kg FVIII, 290 IU/kg VWF) 23.6 1.8 5.1 
Fold difference 20* 34 9 
VWF-ko mouse rD′D3-FP (2.86 mg/kg, 100 IU/kg FVIII) 1.3 49.0 34.0 
NMRI mouse rD′D3-FP (2.86-28.6 mg/kg, 100 IU/kg FVIII) 2.4 ± 0.1 33.0 ± 4.0 26.0 ± 2.0 
Rat rD′D3-FP (0.14-28.6 mg/kg, 200 IU/kg FVIII); rD′D3-FP (2.86-28.6 mg/kg, 100, 300, 1000 IU/kg FVIII) 1.2 ± 0.1; 1.2 ± 0.1 55.1 ± 5.7; 59.5 ± 5.9 39.2 ± 3.9; 42.7 ± 4.2 
VWF (pdVWF, 400 IU/kg) 68.2 1.1 1.3 
Fold difference 59*; 57* 50; 54* 30; 33* 
Rabbit rD′D3-FP (1.4-8.6 mg/kg, 150 IU/kg FVIII) 0.5 ± 0.1 162.0 ± 17.0 112.0 ± 12.0 
VWF (pdVWF, 300 IU/kg) 22.2 4.0 4.2 
Fold difference 44* 41 27 
Cynomolgus monkey rD′D3-FP (7.15-28.6 mg/kg) 0.6-0.7 115.0-151.0 92.0-116.0 
VWF (pdVWF, 500 IU/kg) 5.21 15.5 11.3 
Fold difference 8-9* 7-10 8-10 

Data are mean (± standard deviation) for mice and FVIII-competent rats, rabbits, and cynomolgus monkeys, as well as their improvement over human pdVWF.

CL, clearance.

*

Fold decrease.

Fold increase over human pdVWF.

Two independent studies.

Close Modal

or Create an Account

Close Modal
Close Modal